Last update 08 May 2025

Brexpiprazole

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Brexpiprazole (JAN/USAN/INN), Rxulti, 依匹哌唑
+ [27]
Action
agonists, antagonists
Mechanism
5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), D2 receptor agonists(Dopamine D2 receptor agonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (10 Jul 2015),
RegulationFast Track (United States), Priority Review (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC25H27N3O2S
InChIKeyZKIAIYBUSXZPLP-UHFFFAOYSA-N
CAS Registry913611-97-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Depressive Disorder
Japan
22 Dec 2023
Agitation in Dementia
United States
10 May 2023
Agitation
Australia
19 May 2017
Alzheimer Disease
Australia
19 May 2017
Depressive Disorder, Major
United States
10 Jul 2015
Schizophrenia
United States
10 Jul 2015
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Psychotic DisordersNDA/BLA
China
16 Aug 2024
SchizophreniaNDA/BLA
China
09 Jul 2024
Stress Disorders, Post-TraumaticNDA/BLA
United States
25 Jun 2024
Neurocognitive DisordersPreclinical
Romania
01 Jun 2011
Neurocognitive DisordersPreclinical
Hungary
01 Jun 2011
Neurocognitive DisordersPreclinical
Russia
01 Jun 2011
Neurocognitive DisordersPreclinical
Canada
01 Jun 2011
Neurocognitive DisordersPreclinical
Germany
01 Jun 2011
Neurocognitive DisordersPreclinical
United States
01 Jun 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
321
Brexpiprazole + Sertraline
crhcttoguo(dxxjnfpvsd) = 13.3% for brexpiprazole + placebo clgrmlkale (qkunnvmyqo )
Positive
19 Feb 2025
Sertraline + Placebo
Phase 3
1,149
(yveprohbgw) = jocwsgkksv dqhubmefgh (kedsyfxjpr )
Negative
01 Jan 2025
Placebo + ADT
(yveprohbgw) = zphfmtdhto dqhubmefgh (kedsyfxjpr )
Phase 3
416
Brexpiprazole 2-3 mg + Sertraline 150 mg
(lmjvarlkts) = aanzvagmmk mjlczeahqp (fscwucohlc, 1.2)
Positive
18 Dec 2024
Sertraline 150 mg + Placebo
(lmjvarlkts) = dciztluxtf mjlczeahqp (fscwucohlc, 1.2)
Phase 3
-
(zjkaqigiob) = cjkgqbtvoz jljnwavfvz (glgrlakveo )
Positive
01 Dec 2024
Placebo
(zjkaqigiob) = ncbandhxzm jljnwavfvz (glgrlakveo )
Phase 2/3
247
(rbqmlfcsii) = jegqpgzwuf onsgsclans (fnlstrdjbv )
Positive
01 Dec 2024
Phase 2/3
410
Placebo
bmmogwzhjd(nweqryfkyd) = gybznidjqb mbldjqqlng (xdcgjyhczk, cofqoontws - zqdxcxcbaq)
-
14 Nov 2024
Phase 3
259
(xlvriihucj) = sfmpkczmmd pgccwwmtrn (xuakuvgciv )
Positive
01 Nov 2024
Phase 2/3
201
(zpnrgrdtxe) = pfrhckpubf heulimiuuv (hgnrpjikqx, baynpnafpl - thdyopyhah)
-
03 Oct 2024
Phase 3
164
(ROLLOVER BREX)
jwrxwiqahj(vqvbjsrxrg) = tmodexmjbf gytkrfasnw (nnhqkquqyf, imhryjvjvz - irfexdgznb)
-
19 Sep 2024
placebo
(ROLLOVER PLACEBO)
jwrxwiqahj(vqvbjsrxrg) = uofucqzxja gytkrfasnw (nnhqkquqyf, tiphtqptqu - ipweexcxzq)
Phase 2/3
740
Placebo
ujvdeuaudq(xahrdoszsu) = umadplxusv ivltdvobhw (uqlnnerict, mynpfcfsne - uzeenrfmqw)
-
09 Aug 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free